Sign Up Today and Learn More About Colossal Biosciences Stock
Invest in or calculate the value of your shares in Colossal Biosciences or other pre-IPO companies through EquityZen's platform.
Colossal Biosciences Stock (COLB)
Colossal is a bioscience and genetic engineering company focused on de-extinction of past species.
About Colossal Biosciences Stock
Founded
2021
Headquarters
Dallas, TX, US
Total Funding
558M
Industries
Science and Engineering, Health Care, Biotechnology
Colossal Biosciences is a genetic engineering company attempting to bring back extinct species and preserve threatened ones. The company leverages CRISPR/Cas9 technology and software tools to advance genomic science. Colossal is actively pursing the de-extinction of the woolly mammoth, the Tasmanian tiger, and the dodo with the mission to restore Earth to a healthier state.
Colossal Biosciences was founded in 2021 and is headquartered in Dallas Texas. Notable investors include At One Ventures, Thomas Tull, Draper Associates and U.S. Innovative Technology.Â
Colossal Biosciences Press Mentions
Stay in the know about the latest news on Colossal Biosciences
Ahead of Colossal move, CEO explains science behind $10B valuation
bizjournals • Feb 12, 2025
Colossal Biosciences Hits $10.2B Valuation in Quest to Revive Extinct Species
siliconhillsnews • Feb 10, 2025
Five start-ups that brought heat to January
siliconrepublic • Feb 05, 2025
The $10 billion Jurassic Park-style plan to revive the woolly mammoth and the dodo
thenationalnews • Feb 03, 2025
Startup Raises Rs Rs 3500 Crore To Bring Back Extinct Animals
trak • Jan 25, 2025
Colossal Biosciences Management
Leadership team at Colossal Biosciences
Co-Founder & CEO
Ben Lamm
Co-Founder & Lead Genetics Advisor
George Church
Join now and verify your accreditation status to gain access to:
- Colossal Biosciences Current Valuation
- Colossal Biosciences Stock Price
- Colossal Biosciences Management
- Available deals in Colossal Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Colossal Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Colossal Biosciences Revenue and Financials
- Colossal Biosciences Highlights
- Colossal Biosciences Business Model
- Colossal Biosciences Risk Factors
- Colossal Biosciences Research Report from SACRA Research
Trading Colossal Biosciences Stock
How to invest in Colossal Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Colossal Biosciences through EquityZen funds. These investments are made available by existing Colossal Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Colossal Biosciences stock?
Shareholders can sell their Colossal Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
